FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

732936001: Tablet (unit of presentation)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2017. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3498396015 Tablet (unit of presentation) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3498397012 Tablet en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tablet Is a Unit of presentation true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely etoricoxib 90 milligram and thiocolchicoside 8 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely etoricoxib 90 milligram and thiocolchicoside 8 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely etoricoxib 90 milligram and thiocolchicoside 8 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely valproate sodium 133 milligram and valproic acid 58 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely valproate sodium 133 milligram and valproic acid 58 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely valproate sodium 133 milligram and valproic acid 58 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely valproate sodium 333 milligram and valproic acid 145 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely valproate sodium 333 milligram and valproic acid 145 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely valproate sodium 333 milligram and valproic acid 145 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely valproate sodium 200 milligram and valproic acid 87 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely valproate sodium 200 milligram and valproic acid 87 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely valproate sodium 200 milligram and valproic acid 87 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely ritonavir 25 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely ritonavir 25 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely ritonavir 50 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely ritonavir 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely retinol (as retinol palmitate) 10000 unit/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely retinol (as retinol palmitate) 10000 unit/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely ruxolitinib (as ruxolitinib phosphate) 25 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely ruxolitinib (as ruxolitinib phosphate) 25 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely glimepiride 2 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely glimepiride 2 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely glimepiride 2 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely glimepiride 4 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely glimepiride 4 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely glimepiride 4 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely metformin hydrochloride 500 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely metformin hydrochloride 500 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely metformin hydrochloride 500 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely glimepiride 4 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely glimepiride 4 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely glimepiride 4 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely glimepiride 2 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely glimepiride 2 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely glimepiride 2 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely glimepiride 1 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely glimepiride 1 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely glimepiride 1 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely glimepiride 2 milligram and rosiglitazone (as rosiglitazone maleate) 8 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely glimepiride 2 milligram and rosiglitazone (as rosiglitazone maleate) 8 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely glimepiride 2 milligram and rosiglitazone (as rosiglitazone maleate) 8 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely glimepiride 4 milligram and rosiglitazone (as rosiglitazone maleate) 8 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely glimepiride 4 milligram and rosiglitazone (as rosiglitazone maleate) 8 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely glimepiride 4 milligram and rosiglitazone (as rosiglitazone maleate) 8 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely metformin hydrochloride 500 milligram and sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely metformin hydrochloride 500 milligram and sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely metformin hydrochloride 500 milligram and sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely metformin hydrochloride 850 milligram and sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely metformin hydrochloride 850 milligram and sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely metformin hydrochloride 850 milligram and sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely metformin hydrochloride 1 gram and sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely metformin hydrochloride 1 gram and sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely metformin hydrochloride 1 gram and sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely alogliptin (as alogliptin benzoate) 6.25 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely alogliptin (as alogliptin benzoate) 6.25 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely ropinirole (as ropinirole hydrochloride) 4 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely ropinirole (as ropinirole hydrochloride) 4 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely ropinirole (as ropinirole hydrochloride) 3 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely ropinirole (as ropinirole hydrochloride) 3 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely ropinirole (as ropinirole hydrochloride) 500 microgram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely ropinirole (as ropinirole hydrochloride) 500 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely quetiapine (as quetiapine fumarate) 400 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely quetiapine (as quetiapine fumarate) 400 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely quetiapine (as quetiapine fumarate) 50 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely quetiapine (as quetiapine fumarate) 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely quinagolide (as quinagolide hydrochloride) 25 microgram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely quinagolide (as quinagolide hydrochloride) 25 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely quinagolide (as quinagolide hydrochloride) 50 microgram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely quinagolide (as quinagolide hydrochloride) 50 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely hydrochlorothiazide 25 milligram and quinapril (as quinapril hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely hydrochlorothiazide 25 milligram and quinapril (as quinapril hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely hydrochlorothiazide 25 milligram and quinapril (as quinapril hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely hydrochlorothiazide 12.5 milligram and quinapril (as quinapril hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and quinapril (as quinapril hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely hydrochlorothiazide 12.5 milligram and quinapril (as quinapril hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely naratriptan (as naratriptan hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely naratriptan (as naratriptan hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely terazosin (as terazosin hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely terazosin (as terazosin hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely sertraline (as sertraline hydrochloride) 25 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely sertraline (as sertraline hydrochloride) 25 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely vardenafil (as vardenafil hydrochloride) 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely vardenafil (as vardenafil hydrochloride) 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2

Start Previous Page 78 of 153 Next End

This concept is not in any reference sets

Back to Start